Treatment of Residual Hypermetropic Refraction on Pseudophakic Patients Using Allogenic Fresh Myopic Lenticule
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 30
Summary
- Conditions
- Hypermetropia
- Myopia
- Pseudophakia
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: pseudophakic group hyperopic group myopic groupMasking: None (Open Label)Masking Description: pseudophakic (Trifocal IOL) group 492 patients-246 eyes residual hyperopic group 34 patients-38 eyesPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 19 years and 50 years
- Gender
- Both males and females
Description
This study is to investigate the effect of fresh myopic corneal lenticule implantation as allogenic implant that will be taken from myopic patients to implant on pseudophakic patients(Trifocal IOL) with residual hypermetropic refraction(over +0.50Dsph) using VisuMax Femtosecond laser - Smile module ...
This study is to investigate the effect of fresh myopic corneal lenticule implantation as allogenic implant that will be taken from myopic patients to implant on pseudophakic patients(Trifocal IOL) with residual hypermetropic refraction(over +0.50Dsph) using VisuMax Femtosecond laser - Smile module surgery with primary objective to assess (increase) visual acuity .For example if residual hypermetropic refraction after Trifocal IOL is +1.0Dsph we implant fresh myopic corneal lenticule -1.50Dsph according to high K2 values using corneal topography.
Tracking Information
- NCT #
- NCT04692012
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon